Evidence map›Paper›PMID 34916325›Full record

ArticleBMJ open2021

Assessing the impact of screening, early identification and intervention programmes for chronic kidney disease: protocol for a scoping review.

Ikechi G Okpechi, Fergus J Caskey, Abduzhappar Gaipov, Elliot K Tannor, Laura N Hamonic, Gloria Ashuntantang, Jo-Ann Donner, Ana Figueiredo, Reiko Inagi, Magdalena Madero and 6 more

Abstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ikechi G OkpechiDivision of Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa ikechi.okpechi@uct.ac.za.ORCID 0000-0002-6545-9715
Fergus J CaskeyRichard Bright Renal Unit, North Bristol NHS Trust, Westbury on Trym, UK.
Abduzhappar GaipovDepartment of Medicine, Nazarbaev Universitet, Nur-Sultan, Kazakhstan.
Elliot K TannorDepartment of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Laura N HamonicJohn W. Scott Health Sciences Library, University of Alberta, Edmonton, Alberta, Canada.
Gloria AshuntantangDepartment of Internal Medicine and Subspecialties, University of Yaounde I, Yaounde, Cameroon.
Jo-Ann DonnerGlobal Operations Centre, International Society of Nephrology, Brussels, Belgium.
Ana FigueiredoNursing School, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil.
Reiko InagiDepartment of Medicine, The University of Tokyo Graduate School of Medicine, Bunkyo-ku, Japan.
Magdalena MaderoDepartment of Nephrology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Charu MalikGlobal Operations Centre, International Society of Nephrology, Brussels, Belgium.
Monica MoorthyGlobal Operations Centre, International Society of Nephrology, Brussels, Belgium.
Roberto Pecoits-FilhoDOPPS Program, Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
Vladimir TesarDepartment of Medicine, Charles University, Praha, Czech Republic.
Adeera LevinDepartment of Medicine, The University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada.
Vivekanand JhaThe George Institute for Global Health India, New Delhi, Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionChronic kidney disease (CKD) is a major threat to public health, especially in low-income and lower middle-income countries, where resources for treating patients with advanced CKD are scarce. Although early CKD identification and intervention hold promise for reducing the burden of CKD and risk factors, it remains unclear if an uniform strategy can be applicable across all income groups. The aim of this scoping review is to synthesise available evidence on early CKD identification programmes in all world regions and income groups. The study will also identify efforts that have been made to use interventions and implementation of early identification programmes for CKD across countries and income groups. METHODS AND ANALYSIS: This review will be guided by the methodological framework for conducting scoping studies developed by Arksey and O'Malley. Empirical (Medline, Embase, Cochrane Library, CINAHL, ISI Web of Science and PsycINFO) and grey literature references will be searched to identify studies on CKD screening, early identification and interventions across all populations. Two reviewers will independently screen references in consecutive stages of title/abstract screening and then full-text screening. We will use a general descriptive overview, tabular summaries and content analysis on extracted data. ETHICS AND DISSEMINATION: The findings from our planned scoping review will enable us to identify items in early identification programmes that can be used in developing screening toolkits for CKD. We will disseminate our findings using traditional approaches that include open-access peer-reviewed publication, scientific presentations and a white paper (call to action) report. Ethical approval will not be required for this scoping review as the data will be extracted from already published studies.

Indexed as

Mass ScreeningRenal Insufficiency, ChronicHumansIncomePovertyResearch DesignScoping Reviews as Topicadult nephrologychronic renal failureend stage renal failureepidemiology

Identifiers

PMID34916325
PMCPMC8679109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.